Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.24B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$552M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$535M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$471M |
| 5 |
Palo Alto Networks
PANW
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.11B |
| 2 |
Apple
AAPL
|
+$2.02B |
| 3 |
Microsoft
MSFT
|
+$612M |
| 4 |
Amazon
AMZN
|
+$554M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.61% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.07% |
| 4 | Healthcare | 1.03% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRON
8051
PUT
Cronos Group
CRON
$1.11B
| $52.3K | ﹤0.01% |
+26,200
| New | +$51.2K |
|
|
TWKS
8052
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $52.3K | ﹤0.01% |
12,820
-2,258
| -15% | -$12.8K |
|
|
DFTX
8053
Definium Therapeutics
DFTX
$5.99B
| $52.2K | ﹤0.01% |
+16,584
| New | +$68.2K |
|
8054
MaxCyte
MXCT
$130M
| $52K | ﹤0.01% |
16,679
-14,706
| -47% | -$59.1K |
|
|
SVRN
8055
OceanPal Inc
SVRN
$11.8M
| $51.8K | ﹤0.01% |
+35
| New | +$29.7K |
|
|
WHWK
8056
Whitehawk Therapeutics
WHWK
$259M
| $51.4K | ﹤0.01% |
+10,630
| New | +$61.8K |
|
|
MRSN
8057
CALL
DELISTED
Mersana Therapeutics
MRSN
| $51.3K | ﹤0.01% |
1,616
-1,764
| -52% | -$83.8K |
|
8058
Codexis
CDXS
$161M
| $51.2K | ﹤0.01% |
+27,081
| New | +$63.3K |
|
|
CMAX
8059
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $51.1K | ﹤0.01% |
803
-819
| -50% | -$57.3K |
|
8060
Tenaya Therapeutics
TNYA
$165M
| $51K | ﹤0.01% |
20,000
-71,776
| -78% | -$300K |
|
|
ADVM
8061
DELISTED
Adverum Biotechnologies
ADVM
| $50.8K | ﹤0.01% |
3,388
-1,275
| -27% | -$22.9K |
|
|
ZTR
8062
Virtus Total Return Fund
ZTR
$337M
| $50.8K | ﹤0.01% |
+10,578
| New | +$60.3K |
|
|
EU
8063
enCore Energy
EU
$254M
| $50.2K | ﹤0.01% |
15,400
-75,671
| -83% | -$196K |
|
|
AISPW
8064
Airship AI Holdings Warrants
AISPW
$15.3M
| $49.8K | ﹤0.01% |
221,931
-96
| -0% | -$21 |
|
|
SRTA
8065
Strata Critical Medical Inc
SRTA
$525M
| $49.8K | ﹤0.01% |
19,227
-2,668
| -12% | -$9.37K |
|
8066
PUT
Tilray
TLRY
$602M
| $49.7K | ﹤0.01% |
2,080
-3,630
| -64% | -$85.7K |
|
8067
PUT
FuelCell Energy
FCEL
$1.59B
| $49.7K | ﹤0.01% |
1,293
-1,037
| -45% | -$54.1K |
|
8068
Lineage Cell Therapeutics
LCTX
$286M
| $49.6K | ﹤0.01% |
42,053
+18,633
| +80% | +$25.4K |
|
8069
Latham Group
SWIM
$860M
| $49.4K | ﹤0.01% |
17,640
-25,950
| -60% | -$93.9K |
|
|
FREE
8070
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $49.2K | ﹤0.01% |
13,677
-357
| -3% | -$1.36K |
|
8071
CALL
Senseonics Holdings Inc
SENS
$394M
| $48.7K | ﹤0.01% |
4,030
+1,560
| +63% | +$21.5K |
|
|
DNMR
8072
DELISTED
Danimer Scientific, Inc.
DNMR
| $47.9K | ﹤0.01% |
578
-364
| -39% | -$33K |
|
8073
GameSquare
GAME
$39.9M
| $47.6K | ﹤0.01% |
21,833
+5,454
| +33% | +$15.5K |
|
8074
Microvision
MVIS
$86.9M
| $47.5K | ﹤0.01% |
1,445
-71,474
| -98% | -$3.27M |
|
8075
Precigen
PGEN
$2.51B
| $46.8K | ﹤0.01% |
+32,969
| New | +$46.7K |
|
Similar funds
Jane Street's Q3 2023 Portfolio in Review
As of Q3 2023, Jane Street held 9,820 positions worth $309B, up 4.1% from $297B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jane Street deployed $28.2B of net new capital in Q3 2023, opening 1,242 new positions and adding to 3,523 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Tesla, an estimated $2.11B trimmed.
- Jane Street's largest Q3 2023 buy was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $6.24B increase.
- Jane Street's biggest Q3 2023 reduction was Tesla, cutting an estimated $2.11B.
- Jane Street fully exited iShares Silver Trust in Q3 2023, selling an estimated $130M.
- Jane Street's ten largest holdings make up 40% of its $309B portfolio in Q3 2023.
- Jane Street opened 1,242 new positions and closed 1,288 in Q3 2023.
- Jane Street's portfolio value rose 4.1% quarter-over-quarter to $309B.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.